DrugPatentWatch Database Preview
VERSACLOZ Drug Profile
» See Plans and Pricing
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
US ANDA Litigation and Generic Entry Outlook for Versacloz
A generic version of VERSACLOZ was approved as clozapine by IVAX SUB TEVA PHARMS on November 26th, 1997.
Summary for VERSACLOZ
| International Patents: | 6 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 108 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VERSACLOZ at DailyMed |
Pharmacology for VERSACLOZ
| Drug Class | Atypical Antipsychotic |
US Patents and Regulatory Information for VERSACLOZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VERSACLOZ
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005007168 | Start Trial |
| European Patent Office | 1646393 | Start Trial |
| Canada | 2532648 | Start Trial |
| Spain | 2436213 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
